CEO of 23andMe and New Mountain Capital Plan to Privatize the Genetic Testing Company

The head of 23andMe has partnered with the private equity company, New Mountain Capital, to propose a buyout that would transform the genetic testing firm into a privately held entity. This strategic move places the company’s equity value at…